Experimental Type 1 Diabetes Cell Therapy

A reported 12-person trial combining islet-cell transplantation with an anti-rejection drug has prompted cure claims, but the evidence remains early. A major T1D congress is now foregrounding islet replacement, immune modulation, screening, automated insulin delivery, digital twins, and access; forthcoming announcements require publication-level scrutiny.